Brooks Laboratories Ltd

NSE: BROOKS · BSE: 533543 · Pharmaceuticals & Biotechnology · 19 announcements

Share price: ₹58.78
Market cap: ₹173.2 Cr
Revenue (annual): ₹85.74 Cr
Net profit (annual): ₹24.58 Cr
P/E (TTM): 13.1×Sector 47.3×
Promoter holding: 52.62%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Management Change 3 Financial Results 3 Annual General Meeting 3 Merger & Restructuring 2 Board Meeting Date 2 Debt & Borrowing 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

14 May 2026 18:56 IST BSE

Adverse Business Impact

Brooks Laboratories Adverse Business Impact

Brooks Laboratories announced its associate entity decided to terminate the proposed composite scheme of arrangement. The transaction will not be pursued in its current form.

Read the filing ↗